IPSC
HEALTHYCentury Therapeutics, Inc.
CIK: 0001850119
Buy
(70% confidence)
Last activity: 1 weeks ago
Financial Metrics
As of Dec 31, 2024 (10-K)
Revenue $6.59M
Net Income -$126.57M
Total Cash $58.44M
Total Debt $3.74M
Debt/Equity 0.02
Trend Signals
CEO Buy STRONG
CEO buying activity
Dec 12, 2025
Insider Roster (4 total, 4 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
| Pfeiffenberger Brent President and CEO | 2 | 1 | $33K | 3,322,990 shares $1.94M |
| Cowan Chad Chief Scientific Officer | 1 | 1 | $47K | 1,045,087 shares $887K |
| Carr Douglas SVP Finance & Operations | 0 | 2 | -$725 | 514,551 shares $938K |
| Russotti Gregory See Remarks | 0 | 1 | -$280 | 390,982 shares $208K |
Recent Transactions
SELL Carr Douglas (SVP Finance & Operations)
323 shares @ $1.82
$589
Feb 3, 2026
Conviction: |
View SEC Filing →
BUY Cowan Chad (Chief Scientific Officer)
58,060 shares @ $0.85
$49K
Dec 22, 2025
Conviction: |
View SEC Filing →
BUY Pfeiffenberger Brent (President and CEO)
52,000 shares @ $0.58
$30K
Dec 12, 2025
Conviction: |
View SEC Filing →
SELL Russotti Gregory (See Remarks)
526 shares @ $0.53
$280
Dec 8, 2025
Conviction: |
View SEC Filing →
SELL Carr Douglas (SVP Finance & Operations)
257 shares @ $0.53
$137
Dec 8, 2025
Conviction: |
View SEC Filing →
SELL Cowan Chad (Chief Scientific Officer)
5,462 shares @ $0.50
$3K
Nov 20, 2025
Conviction: |
View SEC Filing →
BUY Pfeiffenberger Brent (President and CEO)
35,000 shares @ $0.50
$17K
Nov 19, 2025
Conviction: |
View SEC Filing →
SELL Pfeiffenberger Brent (President and CEO)
32,456 shares @ $0.45
$15K
Nov 17, 2025
Conviction: |
View SEC Filing →
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.